Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific's reverse split of its common stock has taken effect, the firm announced today.

The 1-for-300 reverse split reduced the number of common stock shares from 199 million to 663,334 and was approved by the Financial Industry Regulatory Authority, following a special shareholder vote.

Also, Great Basin increased its number of authorized shares of common stock from 200 million to 1.5 billion shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.